The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes of anticoagulant (AC) or antiplatelet (AP) use in patients (pts) with chronic lymphocytic leukemia (CLL) or indolent non-Hodgkin’s lymphoma (iNHL) in idelalisib (IDELA) trials.
 
Jacqueline Claudia Barrientos
No Relationships to Disclose
 
Paolo Ghia
Consulting or Advisory Role - Abbvie; Celgene; Gilead Sciences; Roche Pharma AG
Speakers' Bureau - Gilead Sciences
Research Funding - Gilead Sciences; GlaxoSmithKline; Roche Pharma AG
 
John Pagel
No Relationships to Disclose
 
Gilles A. Salles
Honoraria - Amgen; Mundipharma; Roche/Genentech; Sanofi
Consulting or Advisory Role - Celgene; Gilead Sciences; Janssen; Mundipharma; Roche/Genentech
Research Funding - Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Roche/Genentech
 
Jeff Porter Sharman
Honoraria - Genentech
Consulting or Advisory Role - Genentech
Research Funding - Genentech
 
Stephan Stilgenbauer
No Relationships to Disclose
 
Oksana Gurtovaya
No Relationships to Disclose
 
Yeonhee Kim
Employment - Gilead Sciences
Stock and Other Ownership Interests - Gilead Sciences
 
Betsy Philip
Employment - Gilead Sciences
Stock and Other Ownership Interests - Gilead Sciences
 
Andrew David Zelenetz
Honoraria - Celgene; Gilead Sciences
Consulting or Advisory Role - Alissa Pharma; Amgen; Dr. Reddy's Laboratories; Genentech/Roche; Gilead Sciences; Hospira
Research Funding - Bristol-Myers Squibb; Genentech/Roche; Gilead Sciences
Travel, Accommodations, Expenses - Celgene; Kirin Pharmaceuticals
Other Relationship - Boehringer Ingelheim